Nimacimab

Tax included
Nimacimab (RYI-018) is a negative-allosteric modulating monoclonal antibody targeting CB1 receptor. Nimacimab can be used for research of metabolic diseases.
MedChemExpress 
HY-P99755

Data sheet

Size
Multiple sizes
Reactivity
Cannabinoid Receptor
CAS
2098636-09-8